Lupin zooms on turning black in Q2FY23

Lupin is currently trading at Rs. 731.85, up by 37.80 points or 5.45% from its previous closing of Rs. 694.05 on the BSE.

lupin surges on getting tentative usfda approval for mirabegron extended release tablets
Lupin

The scrip opened at Rs. 714.00 and has touched a high and low of Rs. 753.90 and Rs. 714.00 respectively. So far 154952 shares were traded on the counter.

The BSE group ‘A’ stock of face value Rs. 2 has touched a 52 week high of Rs. 972.50 on 14-Dec-2021 and a 52 week low of Rs. 583.05 on 25-May-2022.

Last one week high and low of the scrip stood at Rs. 753.90 and Rs. 688.35 respectively. The current market cap of the company is Rs. 32990.17 crore.

The promoters holding in the company stood at 47.11%, while Institutions and Non-Institutions held 41.44% and 11.45% respectively.

Lupin reported results for second quarter ended September 30, 2022.

The company has reported net profit of Rs 148.62 crore for Q2FY23 as compared to net loss Rs 1,329.12 crore for the corresponding quarter previous year. However, total income of the company decreased by 3.41% to Rs 2,844.33 crore for the quarter under review as compared to Rs 2,944.85 crore for the same quarter in the previous year.

On the consolidated basis, the company has reported net profit of Rs 134.47 crore for the quarter under review as compared to net loss of Rs 2,094.87 crore for the same quarter in the previous year. However, total income of the company decreased by 0.09% to Rs 4,160.46 crore for the quarter under review as compared to Rs 4,164.14 crore for the same quarter in the previous year.

Leave a Comment